0001104659-21-100290.txt : 20210804
0001104659-21-100290.hdr.sgml : 20210804
20210804210710
ACCESSION NUMBER: 0001104659-21-100290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BURGESS DANIEL D
CENTRAL INDEX KEY: 0001239650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 211145922
MAIL ADDRESS:
STREET 1: C/O HOLLIS-EDEN PHARMACEUTICALS
STREET 2: 4435 EASTGATE MALL STE.400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2123911-7_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-02
0
0001641640
Nabriva Therapeutics plc
NBRV
0001239650
BURGESS DANIEL D
414 COMMERCE DRIVE
SUITE 120
FORT WASHINGTON
PA
19034
1
0
0
0
Ordinary Shares
2021-08-02
4
S
0
1125
1.20
D
21725
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Robert Crotty, by power of attorney
2021-08-04